title: Author's reply to: Effectiveness of anti-VEGF treatment on ophthalmic radiation side effects.
authors.affiliation: The New York Eye Cancer Center, New York, New York - USA.
authors.forename: Paul T
authors.initials: PT
authors.lastname: Finger
authors.affiliation: The New York Eye Cancer Center, New York, New York - USA.
authors.forename: Kimberly J
authors.initials: KJ
authors.lastname: Chin
authors.affiliation: The New York Eye Cancer Center, New York, New York - USA.
authors.forename: Ekaterina A
authors.initials: EA
authors.lastname: Semenova
mesh_terms: D000068258:Bevacizumab; D005123:Eye; D006801:Humans; D011832:Radiation Injuries; D042461:Vascular Endothelial Growth Factor A
chemical_list: D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab